SCHEMBL29527291

SCHEMBL29527291

[2H]C1=NC([2H])=C(N)NN1c1cc(Cl)c(Oc2cc(C)c(=O)n(C(C)C)c2)c(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29527642 0.90 — —
SCHEMBL29527397 0.77 NPBWR1 (0.34) —
SCHEMBL24407940 0.73 THRB (0.56) —
SCHEMBL29527046 0.73 NPBWR1 (0.34) —
SCHEMBL29526904 0.70 NPBWR1 (0.37) —
SCHEMBL29066210 0.70 THRA (0.61) —
SCHEMBL29527017 0.69 MEN1 (0.39) —
SCHEMBL29527727 0.69 THRB (0.30) —
SCHEMBL30511714 0.68 CYP3A4 (0.32) —
SCHEMBL29066201 0.67 THRA (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240730-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS Aligos Therapeutics, Inc. (US) 2023-09-13 — — EP disclosed
WO-2022099044-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS ALIGOS THERAPEUTICS, INC. (US) 2022-05-12 — — WO disclosed
Send feedback